Emerging at the UK, retatrutide, a novel peptide , is creating considerable interest within the healthcare community regarding its promise for weight management . This dual GIP and GLP-1 target agonist seems to deliver a significant advantage over current therapies, showing promising results in initial clinical studies . Researchers believe its … Read More